Skip to content

A single-center trial to evaluate the efficacy and safety of AI-assisted systems in the diagnosis of digestive diseases

A single-center trial to evaluate the efficacy and safety of AI-assisted systems in the diagnosis of digestive diseases

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400086606
Enrollment
Unknown
Registered
2024-07-08
Start date
2024-07-08
Completion date
Unknown
Last updated
2024-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

digestive diseases

Interventions

Control group:Physicians carry out clinical and therapeutic activities independently, such as taking medical histories, writing medical records, recording diagnoses and treatments, and giving medical
AI assisted group:Clinical diagnostic and therapeutic activities, such as history taking, writing medical records, recording diagnostic and therapeutic findings, and giving medical advice, are perform

Sponsors

Renmin Hospital of Wuhan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1) Male or female aged 18 years or above; 2) Patients who have symptoms or diseases related to the digestive system and whose condition requires hospitalisation for further diagnosis; 3) Patients who are able to read, understand and sign the informed consent form; 4) The investigator believes that the subject understands the clinical trial procedures, is willing and able to complete all trial procedures and follow-up visits, and will cooperate with the trial procedures.

Exclusion criteria

Exclusion criteria: 1) Patients who have participated in other clinical trials and are within the follow-up period of the other clinical trials. 2) High-risk diseases or other special conditions that, in the opinion of the investigator, make the subject unsuitable for participation in a clinical trial; and 3) Other uncooperative patients.

Design outcomes

Primary

MeasureTime frame
Accuracy of disease diagnosis;Diagnosis and treatment quality control indicators;

Secondary

MeasureTime frame
Time required for diagnosis;Accuracy of disease feature extraction;Diagnostic consistency;Sensibility;Mortality rate;Specificity;Positive predictive value;Negative predictive value;diagnostic relevance;Incidence of adverse events;

Countries

China

Contacts

Public ContactHonggang Yu

Renmin Hospital of Wuhan University

yuhonggang1968@163.com+86 138 7128 1899

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026